Physician profile
Katherine E Badecker
NPI 1912507641
$3,774.70
in general payments reported to CMS, 2019-2025
38 companies · $590 in 2025
The $590 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $870 · 2022: $1,112 · 2023: $381 · 2024: $822 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,793.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $769.98 | 2021-2025 | |
| Lilly USA, LLC | $555.38 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $371.27 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $330.27 | 2021-2025 | Airsupra |
| Amgen INC. | $270.53 | 2021-2025 | Otezla, Repatha, Uplizna |
| Bayer Healthcare Pharmaceuticals INC. | $175.90 | 2022-2025 | |
| Glaxosmithkline, LLC. | $163.17 | 2021-2023 | Arexvy, Shingrix |
| Pfizer INC. | $129.85 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.34 | 2023-2025 | Jardiance |
| Astellas Pharma US INC | $85.74 | 2024-2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.56 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $59.04 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $56.21 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $55.35 | 2021 | |
| Exact Sciences Corporation | $50.01 | 2025 | Cologuard Collection Kit |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Badecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.